The IPT is part of the Cluster for Nucleic Acid Therapeutics Munich (CNATM). CNATM is on of the seven winners of the Clusters4Future initiative of the German Ministry for Research, Technology and Space (BMFTR). The research consortium consists of research groups from the leading universities LMU and TU, researchers from the universities of Regensburg and Würzburg, as well as the Helmholtz center Munich, and 14 industrial partners from the Munich area.